• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

    6/6/24 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email

    SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer.

    (PRNewsfoto/Health Catalyst)

    Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care. In combination with Carevive, Health Catalyst will have a strengthened ability to support care and process improvement in oncology and gain new insight into patient-reported outcomes and oncology registry data.

    "We are thrilled to welcome Carevive to Health Catalyst. Oncology is one of the most strategic and important delivery programs within any health system, and access to high-quality data is essential to its success. We are grateful to have the opportunity to work alongside Carevive, a team that is mission-aligned and deeply committed to leveraging data and analytics to improve patient care and outcomes in this space," said Dan Burton, CEO of Health Catalyst.

    "Today marks a pivotal moment for our patients and clients. At Carevive, we're thrilled and deeply honored to join forces with Health Catalyst. This partnership embodies our shared commitment to advancing healthcare through the strategic utilization of technology, data, and analytics within healthcare organizations," said Bruno Lempernesse, CEO of Carevive. "Central to Carevive's mission is amplifying the patient's voice in cancer care. By uniting with Health Catalyst, we're not just expanding our capabilities; we're also enhancing our ability to make a difference. With their expertise and solutions augmenting ours, Carevive is poised to deliver even more innovative solutions to cancer centers and provide researchers with unparalleled real-world data. Together, we're shaping a future where patient-centered care and groundbreaking research converge seamlessly."

    About Health Catalyst

    Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

    Media Contact:

    Amanda Hundt

    Vice President, Corporate Communications

    [email protected]

    575-491-0974

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-acquires-oncology-focused-health-technology-company-carevive-302165472.html

    SOURCE Health Catalyst

    Get the next $HCAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    3/18/2026$1.00Overweight → Equal Weight
    Wells Fargo
    8/27/2025$4.00Overweight → Neutral
    Piper Sandler
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $HCAT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst Inc

    SCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)

    3/13/26 8:09:08 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-8 filed by Health Catalyst Inc

    S-8 - Health Catalyst, Inc. (0001636422) (Filer)

    3/12/26 5:10:29 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form 10-K filed by Health Catalyst Inc

    10-K - Health Catalyst, Inc. (0001636422) (Filer)

    3/12/26 4:58:47 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Health Catalyst downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00

    3/18/26 8:20:46 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/27/25 8:19:35 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Fourth Quarter and Year End 2025 Results

    SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the

    3/12/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026

    SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ425." A live audio webcast will be available online at https://ir.healthc

    3/2/26 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.

    2/18/26 8:55:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Albert Benjamin covered exercise/tax liability with 70,455 shares, decreasing direct ownership by 5% to 1,457,978 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    3/13/26 8:13:32 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    General Counsel Landry Benjamin covered exercise/tax liability with 20,838 shares, decreasing direct ownership by 5% to 378,318 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    3/5/26 6:48:30 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Alger Jason covered exercise/tax liability with 26,970 shares, decreasing direct ownership by 4% to 741,644 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    3/5/26 6:48:14 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.

    2/18/26 8:55:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

    SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o

    12/2/25 6:59:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Healthmine Appoints Dwight Erskine as New Chief Executive Officer

    Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins Healthmine as a seasoned leader with more than 25 years of experience in healthcare technology, transformation and analytics. He most recently served as Senior Vice President of Enterprise Transformation at VillageMD where he led the streamlining of clinical operations and scale value-based care delivery across the organization. Prio

    9/24/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports Fourth Quarter and Year End 2025 Results

    SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the

    3/12/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026

    SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ425." A live audio webcast will be available online at https://ir.healthc

    3/2/26 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Third Quarter 2025 Results

    SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. "For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure," said Dan Burton, CEO of Health Catalyst. "By focusing on high-impact solutions with proven ROI and maintaining a commitment to understanding and evolving with our clients, we have reaffirmed our full-year

    11/10/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology